Home › Funds › BOSTON RESEARCH & MANAGEMENT INC › MRK

BOSTON RESEARCH & MANAGEMENT INC position in MRK

MERCK & CO · Health Care

BOSTON RESEARCH & MANAGEMENT INC reported holding 64,862 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 2.08% of its reported portfolio and ranking #11 among its reported holdings. BOSTON RESEARCH & MANAGEMENT INC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)64.86K sh
Reported value held$9.43M
Portfolio Weight2.08%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BOSTON RESEARCH & MANAGEMENT INC's MRK position evolved

BOSTON RESEARCH & MANAGEMENT INC first disclosed a stake in MRK in Q3 2023 at 60,110 shares (US$6.2M). The position peaked in Q3 2026 at 64,862 shares, worth US$9.4M. Across 13 filings, BOSTON RESEARCH & MANAGEMENT INC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 64,862 shares valued at US$9.4M — a reduction of -983 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 60.11K $6.19M New
Q4 2023 61.52K $6.71M Add
Q1 2024 61.52K $8.12M Hold
Q2 2024 60.76K $7.52M Reduce
Q3 2024 63.04K $7.16M Add
Q4 2024 64.79K $6.44M Add
Q1 2025 63.60K $5.71M Reduce
Q2 2025 67.62K $5.35M Add
Q3 2025 67.61K $5.67M Hold
Q4 2025 65.99K $6.95M Reduce
Q1 2026 66.57K $8.01M Add
Q2 2026 65.84K $8.46M Reduce
Q3 2026 64.86K $9.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has BOSTON RESEARCH & MANAGEMENT INC held MRK?

BOSTON RESEARCH & MANAGEMENT INC has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BOSTON RESEARCH & MANAGEMENT INC's current position in MRK?

As of Q3 2026, BOSTON RESEARCH & MANAGEMENT INC holds 64.86K shares of MRK (MERCK & CO), valued at $9.43M, representing 2.08% of its reported portfolio and ranking #11.

Has BOSTON RESEARCH & MANAGEMENT INC been buying or selling MRK?

In the latest 13F filing (Q3 2026), BOSTON RESEARCH & MANAGEMENT INC reduced its position in MRK. The position peaked in Q3 2026 at 64.86K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.